Jolanta M. Siller-Matula Department of Internal Medicine II, Division of Cardiology Medical University of Vienna Biography Publications Institution JoVE Articles Jolanta M. Siller-Matula has not added a biography. If you are Jolanta M. Siller-Matula and would like to personalize this page please email our Author Liaison for assistance. Publications Sex Differences in Treatment and Outcomes in Non-ST-Elevation Acute Coronary Syndrome: A Persistent Disparity Circulation. Cardiovascular Interventions. Jan, 2021 | Pubmed ID: 33430605 Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysis American Journal of Therapeutics. Dec, 2020 | Pubmed ID: 33395057 Right Ventricular Function and Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement European Heart Journal Cardiovascular Imaging. Dec, 2020 | Pubmed ID: 33377480 Editorial: Antithrombotic Treatment in Transcatheter Structural Cardiac Interventions and After Cardiac Device Implantation Frontiers in Cardiovascular Medicine. 2020 | Pubmed ID: 33282921 ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors Journal of Clinical Medicine. Nov, 2020 | Pubmed ID: 33233425 Cardiac Arrest and Related Mortality in Emergency Departments in the United States: Analysis of the Nationwide Emergency Department Sample Resuscitation. Dec, 2020 | Pubmed ID: 33086085 Prolonged Antithrombotic Therapy in Patients After Acute Coronary Syndrome: A Critical Appraisal of Current European Society of Cardiology Guidelines Cardiology Journal. 2020 | Pubmed ID: 33073857 MicroRNAs As Biomarkers of Systemic Changes in Response to Endurance Exercise-A Comprehensive Review Diagnostics (Basel, Switzerland). Oct, 2020 | Pubmed ID: 33066215 MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets Cardiology Clinics. Nov, 2020 | Pubmed ID: 33036721 Interleukin-6 Level is a Powerful Predictor of Long-term Cardiovascular Mortality in Patients with Acute Coronary Syndrome Vascular Pharmacology. Dec, 2020 | Pubmed ID: 33035661 Antithrombotic Management and Outcomes of Patients with Atrial Fibrillation Treated with NOACs Early at the Time of Market Introduction: Main Results from the PREFER in AF Prolongation Registry Internal and Emergency Medicine. Sep, 2020 | Pubmed ID: 32955677 Medication Adherence and Its Determinants in Patients After Myocardial Infarction Scientific Reports. 07, 2020 | Pubmed ID: 32694522 Von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo Thrombosis and Haemostasis. Sep, 2020 | Pubmed ID: 32679592 Updated Overview of Evidence on Optimal Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutanous Coronary Intervention Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology. Jun, 2020 | Pubmed ID: 32636896 Adaptive Development of Concomitant Secondary Mitral and Tricuspid Regurgitation After Transcatheter Aortic Valve Replacement European Heart Journal Cardiovascular Imaging. Jun, 2020 | Pubmed ID: 32561917 Ticagrelor and Prasugrel Are Independent Predictors of Improved Long-term Survival in ACS Patients European Journal of Clinical Investigation. Nov, 2020 | Pubmed ID: 32506444 Prediction for Contrast Volume in Transcatheter Aortic Valve Replacement - Important but Modifiable? Cardiology. 2020 | Pubmed ID: 32506061 Inflammatory State Does Not Affect the Antiplatelet Efficacy of Potent P2Y12 Inhibitors in ACS Platelets. Jun, 2020 | Pubmed ID: 32501749 Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium Clinical Pharmacology and Therapeutics. May, 2020 | Pubmed ID: 32472697 Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type Journal of Clinical Medicine. Apr, 2020 | Pubmed ID: 32295160 Antithrombotic Agents for Primary and Secondary Prevention of Cardiovascular Events in Patients with End-stage Renal Disease on Chronic Hemodialysis Atherosclerosis. 04, 2020 | Pubmed ID: 32126388 Antithrombotic Therapy in Patients with Acute Coronary Syndrome Complicated by Cardiogenic Shock or Out-of-hospital Cardiac Arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in Association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) European Heart Journal. Cardiovascular Pharmacotherapy. 02, 2020 | Pubmed ID: 32049278 Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis Clinical Pharmacology and Therapeutics. Jul, 2020 | Pubmed ID: 31990051 Sex and Gender in Cardiovascular Medicine: Presentation and Outcomes of Acute Coronary Syndrome European Heart Journal. Apr, 2020 | Pubmed ID: 31876924 Transcatheter Versus Surgical Aortic Valve Replacement in Low-risk Patients: a Meta-analysis of Randomized Trials Clinical Research in Cardiology : Official Journal of the German Cardiac Society. Jun, 2020 | Pubmed ID: 31863174 Ticagrelor Attenuates the Increase of Extracellular Vesicle Concentrations in Plasma After Acute Myocardial Infarction Compared to Clopidogrel Journal of Thrombosis and Haemostasis : JTH. 03, 2020 | Pubmed ID: 31833175 Pharmacogenomic Polygenic Response Score Predicts Ischaemic Events and Cardiovascular Mortality in Clopidogrel-treated Patients European Heart Journal. Cardiovascular Pharmacotherapy. Jul, 2020 | Pubmed ID: 31504375 Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers Clinical Pharmacology and Therapeutics. 02, 2020 | Pubmed ID: 31442298 Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing Frontiers in Cardiovascular Medicine. 2019 | Pubmed ID: 31850373 Bioresorbable Vascular Scaffolds-Dead End or Still a Rough Diamond? Journal of Clinical Medicine. Dec, 2019 | Pubmed ID: 31817876 Aspirin for Primary Prevention of Cardiovascular Disease: a Meta-analysis with a Particular Focus on Subgroups BMC Medicine. 11, 2019 | Pubmed ID: 31679516 Transcatheter Aortic Valve Replacement Is Associated with Less Oxidative Stress and Faster Recovery of Antioxidant Capacity Than Surgical Aortic Valve Replacement Journal of Clinical Medicine. Sep, 2019 | Pubmed ID: 31480644 Significance of Circulating MicroRNAs in Diabetes Mellitus Type 2 and Platelet Reactivity: Bioinformatic Analysis and Review Cardiovascular Diabetology. 08, 2019 | Pubmed ID: 31470851 Shedding Light on Long-Term Effects of Early Antiplatelet Strategies After Fibrinolytic Treatment in STEMI Journal of the American College of Cardiology. 06, 2019 | Pubmed ID: 31171088 Incidence, Predictors, and Prognosis of Premature Discontinuation or Switch of Prasugrel or Ticagrelor: the ATLANTIS - SWITCH Study Scientific Reports. 06, 2019 | Pubmed ID: 31160687 Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review Clinical Pharmacology and Therapeutics. 11, 2019 | Pubmed ID: 31055838 [Aortic Valve Disease] MMW Fortschritte Der Medizin. 04, 2019 | Pubmed ID: 30937769 Risk Factors for Thromboembolic and Bleeding Events in Anticoagulated Patients with Atrial Fibrillation: the Prospective, Multicentre Observational PREvention OF Thromboembolic Events - European Registry in Atrial Fibrillation (PREFER in AF) BMJ Open. 03, 2019 | Pubmed ID: 30928922 Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis Thrombosis and Haemostasis. Jun, 2019 | Pubmed ID: 30919382 Platelet Reactivity Patterns in Patients Treated with Dual Antiplatelet Therapy European Journal of Clinical Investigation. Mar, 2019 | Pubmed ID: 30882911 Thrombotic and Hemorrhagic Burden in Women: Gender-related Issues in the Response to Antithrombotic Therapies International Journal of Cardiology. 07, 2019 | Pubmed ID: 30777407 Switching Between P2Y Antagonists - From Bench to Bedside Vascular Pharmacology. 04, 2019 | Pubmed ID: 30685502 Assessment of Adherence to Medication in Patients After Myocardial Infarction Treated with Percutaneous Coronary Intervention. Is There a Place for Newself-reported Questionnaires? Current Medical Research and Opinion. 02, 2019 | Pubmed ID: 30091642 Cangrelor Induces More Potent Platelet Inhibition Without Increasing Bleeding in Resuscitated Patients Journal of Clinical Medicine. Nov, 2018 | Pubmed ID: 30445678 Coming Closer to Personalized Medicine in Transcatheter Aortic Valve Replacement JACC. Cardiovascular Interventions. 09, 2018 | Pubmed ID: 30190062 Heart Failure Subtypes and Thromboembolic Risk in Patients with Atrial Fibrillation: The PREFER in AF - HF Substudy International Journal of Cardiology. Aug, 2018 | Pubmed ID: 29706429 Genome-wide and Candidate Gene Approaches of Clopidogrel Efficacy Using Pharmacodynamic and Clinical End Points-Rationale and Design of the International Clopidogrel Pharmacogenomics Consortium (ICPC) American Heart Journal. 04, 2018 | Pubmed ID: 29653637 Ticagrelor - Toward More Efficient Platelet Inhibition and Beyond Therapeutics and Clinical Risk Management. 2018 | Pubmed ID: 29398917 Clopidogrel in Critically Ill Patients Clinical Pharmacology and Therapeutics. 02, 2018 | Pubmed ID: 28913918 Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (vention O Thromboembolic Events-uropean Egistry in Trial Ibrillation) Journal of the American Heart Association. Jul, 2017 | Pubmed ID: 28736385 Interdependence Between Osteoprotegerin and Active Von Willebrand Factor in Long-term Cardiovascular Mortality Prediction in Patients Undergoing Percutaneous Coronary Intervention Thrombosis and Haemostasis. 08, 2017 | Pubmed ID: 28726980 Platelets Redox Balance Assessment: Current Evidence and Methodological Considerations Vascular Pharmacology. 08, 2017 | Pubmed ID: 28684282 Advocating Cardiovascular Precision Medicine with P2Y12 Receptor Inhibitors European Heart Journal. Cardiovascular Pharmacotherapy. 10, 2017 | Pubmed ID: 28204303 Association of PCSK9 with Platelet Reactivity in Patients with Acute Coronary Syndrome Treated with Prasugrel or Ticagrelor: The PCSK9-REACT Study International Journal of Cardiology. Jan, 2017 | Pubmed ID: 27810295 Impact of Preoperative Use of P2Y12 Receptor Inhibitors on Clinical Outcomes in Cardiac and Non-cardiac Surgery: A Systematic Review and Meta-analysis European Heart Journal. Acute Cardiovascular Care. Dec, 2017 | Pubmed ID: 25943554 Abciximab As a Bridging Strategy to Overcome Morphine-prasugrel Interaction in STEMI Patients British Journal of Clinical Pharmacology. 11, 2016 | Pubmed ID: 27366874 Distribution of Clinical Events Across Platelet Aggregation Values in All-comers Treated with Prasugrel and Ticagrelor Vascular Pharmacology. Apr, 2016 | Pubmed ID: 26804766 Inter-patient Variability of Platelet Reactivity in Patients Treated with Prasugrel and Ticagrelor Platelets. Jun, 2016 | Pubmed ID: 26555925 Personalized Antiplatelet Therapy with P2Y12 Receptor Inhibitors: Benefits and Pitfalls Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology. 2015 | Pubmed ID: 26677375 Bleeding and Stent Thrombosis on P2Y12-inhibitors: Collaborative Analysis on the Role of Platelet Reactivity for Risk Stratification After Percutaneous Coronary Intervention European Heart Journal. Jul, 2015 | Pubmed ID: 25896078 Evaluation of Clinical Risk Factors to Predict High On-treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE) PloS One. 2015 | Pubmed ID: 25799149 How to Improve the Concept of Individualised Antiplatelet Therapy with P2Y12 Receptor Inhibitors--is an Algorithm the Answer? Thrombosis and Haemostasis. Jan, 2015 | Pubmed ID: 25231675 The Net Clinical Benefit of Personalized Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention Clinical Science (London, England : 1979). Jan, 2015 | Pubmed ID: 25124236 Individualising Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: the IDEAL-PCI Registry BMJ Open. Oct, 2014 | Pubmed ID: 25361837 Interplay Between Genetic and Clinical Variables Affecting Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention PloS One. 2014 | Pubmed ID: 25051347 [Dual Platelet Inhibitors in Intensive Care Units] Medizinische Klinik, Intensivmedizin Und Notfallmedizin. Sep, 2014 | Pubmed ID: 24986549 Association Between the Rs342293 Polymorphism and Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention Thrombosis and Haemostasis. Jun, 2014 | Pubmed ID: 24652536 Response Variability to P2Y12 Receptor Inhibitors: Expectations and Reality JACC. Cardiovascular Interventions. Nov, 2013 | Pubmed ID: 24262612 Why Have Studies of Tailored Anti-platelet Therapy Failed So Far? Thrombosis and Haemostasis. Oct, 2013 | Pubmed ID: 23884166 Personalized Antiplatelet Treatment After Percutaneous Coronary Intervention: the MADONNA Study International Journal of Cardiology. Sep, 2013 | Pubmed ID: 22656044 Dual Non-responsiveness to Antiplatelet Treatment is a Stronger Predictor of Cardiac Adverse Events Than Isolated Non-responsiveness to Clopidogrel or Aspirin International Journal of Cardiology. Jul, 2013 | Pubmed ID: 22305813 Effects of Prasugrel on Platelet Inhibition During Systemic Endotoxaemia: a Randomized Controlled Trial Clinical Science (London, England : 1979). Nov, 2012 | Pubmed ID: 22646240 Continuous Thrombin Infusion Leads to a Bleeding Phenotype in Sheep Thrombosis Research. Jan, 2012 | Pubmed ID: 22289207 ARC15105 is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion Arteriosclerosis, Thrombosis, and Vascular Biology. Apr, 2012 | Pubmed ID: 22282355 The Effect of Erythropoietin on Platelet and Endothelial Activation Markers: a Prospective Trial in Healthy Volunteers Platelets. 2012 | Pubmed ID: 22098110 Thrombin As a Multi-functional Enzyme. Focus on in Vitro and in Vivo Effects Thrombosis and Haemostasis. Dec, 2011 | Pubmed ID: 21979864 Addition of Omeprazole to Dual Antiplatelet Therapy with Clopidogrel Plus Aspirin Lowers the Risk of Upper Gastrointestinal Bleeding Evidence-based Medicine. Oct, 2011 | Pubmed ID: 21558563 Impact of Clopidogrel Loading Dose on Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis Heart (British Cardiac Society). Jan, 2011 | Pubmed ID: 20736210 Ticagrelor: from Discovery to Phase III Clinical Trial Future Cardiology. Nov, 2010 | Pubmed ID: 21142630 Targeting Von Willebrand Factor and Platelet Glycoprotein Ib Receptor Expert Review of Cardiovascular Therapy. Dec, 2010 | Pubmed ID: 21108551 An Experimental Model to Study Isolated Effects of Thrombin in Vivo Thrombosis Research. Nov, 2010 | Pubmed ID: 20869757 The Aptamer ARC1779 Blocks Von Willebrand Factor-dependent Platelet Function in Patients with Thrombotic Thrombocytopenic Purpura Ex Vivo Transfusion. May, 2010 | Pubmed ID: 20070617 Pharmacokinetic, Pharmacodynamic and Clinical Profile of Novel Antiplatelet Drugs Targeting Vascular Diseases British Journal of Pharmacology. Feb, 2010 | Pubmed ID: 20050853 Cross Validation of the Multiple Electrode Aggregometry. A Prospective Trial in Healthy Volunteers Thrombosis and Haemostasis. Aug, 2009 | Pubmed ID: 19652892 The Effect of Antiplatelet Drugs Clopidogrel and Aspirin is Less Immediately After Stent Implantation Thrombosis Research. Apr, 2009 | Pubmed ID: 19135705 Effects of Pantoprazole and Esomeprazole on Platelet Inhibition by Clopidogrel American Heart Journal. Jan, 2009 | Pubmed ID: 19081411 Calcium-channel Blockers Reduce the Antiplatelet Effect of Clopidogrel Journal of the American College of Cardiology. Nov, 2008 | Pubmed ID: 19007592 Reproducibility and Standardized Reporting of the Vasodilator-stimulated Phosphoprotein Phosphorylation Assay Platelets. Nov, 2008 | Pubmed ID: 18979368 Interspecies Differences in Coagulation Profile Thrombosis and Haemostasis. Sep, 2008 | Pubmed ID: 18766254 The Intra-Aortic Balloon Pump Ganesh Gajanan1, Emmanouil S. Brilakis2, Jolanta M. Siller-Matula3,4,5, Ronald L. Zolty1, Poonam Velagapudi1 1Division of Cardiovascular Medicine, University of Nebraska Medical Center, 2Minneapolis Heart Institute, 3Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 4Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, 5Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna JoVE 62132 Medicina
The Intra-Aortic Balloon Pump Ganesh Gajanan1, Emmanouil S. Brilakis2, Jolanta M. Siller-Matula3,4,5, Ronald L. Zolty1, Poonam Velagapudi1 1Division of Cardiovascular Medicine, University of Nebraska Medical Center, 2Minneapolis Heart Institute, 3Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 4Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, 5Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna JoVE 62132 Medicina